Correlation between HIF-1α expression and breast cancer risk: A meta-analysis

Breast Journal

Volumn 20, Issue 2, 2014, Pages 213-215

  Sun, Guogui ^a   Wang, Yadi ^b   Hu, Wanning ^a  

^a Hebei United University   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN; HIF1A PROTEIN, HUMAN; TUMOR MARKER;

AXILLARY LYMPH NODE; BREAST CANCER; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RISK; DISEASE ASSOCIATION; HUMAN; LETTER; LYMPH NODE METASTASIS; META ANALYSIS (TOPIC); PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; BREAST TUMOR; FEMALE; LYMPH NODE; META ANALYSIS; METABOLISM; MORTALITY; PATHOLOGY; PROGNOSIS; RISK; RISK FACTOR;

BREAST NEOPLASMS; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LYMPH NODES; LYMPHATIC METASTASIS; ODDS RATIO; PROGNOSIS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84896316987     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/tbj.12238     Document Type: Letter

References (18)

1. van Diest PJ, Vleugel MM, van der Groep P, van der Wall E,. VEGF-D and HIF-1alpha in breast cancer. J Clin Pathol 2005; 58: 335; author reply 336.
2. Carmeliet P, Jain RK,. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011; 473: 298-307.
3. Gruber G, Greiner RH, Hlushchuk R, et al,. Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter? Breast Cancer Res 2004; 6: R191-8.
4. Brito LG, Schiavon VF, Andrade JM, Tiezzi DG, Peria FM, Marana HR,. Expression of Hypoxia-inducible factor 1-alpha and vascular endothelial growth factor-C in locally advanced breast cancer patients. Clinics (Sao Paulo) 2011; 66: 1313-20.
5. Vleugel MM, Greijer AE, Shvarts A, et al,. Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer. J Clin Pathol 2005; 58: 172-7.
6. Trastour C, Benizri E, Ettore F, et al,. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome. Int J Cancer 2007; 120: 1451-8.
7. Bos R, Zhong H, Hanrahan CF, et al,. Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst 2001; 93: 309-14.
8. Bos R, van Diest PJ, de Jong JS, et al,. Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. Histopathology 2005; 46: 31-6.
9. Yamamoto Y, Ibusuki M, Okumura Y, et al,. Hypoxia-inducible factor 1alpha is closely linked to an aggressive phenotype in breast cancer. Breast Cancer Res Treat 2008; 110: 465-75.
10. Yang WG, Li XH,. Expression and significance of Survivin, HIF-1α in breast carcinoma. China J Modern Med 2008; 18: 72-5.
11. Ma C, Zhou GY, Xiao Y, Gao P, Guo LL, Lin XY,. Expression of HIF-1α and P-gp in axillary node-negative breast carcinoma. Chin J Clin Oncol 2007; 34: 10-3.
12. Sun WZ, Yu LB, Zhang QY,. Expression and role of HIF-1α in carcinogenesis and progression of breast cancer. J Fourth Military Med Univ 2007; 28: 163-5.
13. Feng YQ, Wang ZF, Gu YT, Zhang LP,. Expression and clinical significance of hypoxia-inducible factor-1α and Bak in breast cancer. J Basic Clin Oncol 2006; 19: 96-8.
14. Zhang JH, Wang JF, Tang XY, Qiu SL,. Expression and significance of HIF-1α and CXCR4 protein in tissues of breast cancer. J Shanghai Jiaotong Univ (Medical Science) 2008; 28: 1568-71.
15. Ma ZS, Dai YC, Xie BJ, Cao FL,. Expression and significance of HIF-1α and Caspase-3 in breast cancer. J Modern Oncol 2011; 19: 2216-9.
16. Sun YY, Xu XY,. The expression of HIF-1α and VEGF and their relationship in breast cancer. Journal of Pactical Oncology 2006; 20: 282-5.
17. Chen J, Chen FL,. Expressions of Survivin and HIF-1α in breast cancer and their clinical significance. Chin J Cancer Prev Treat 2008; 15: 765-8.
18. Hao LS, Wang G, Qian K, Luo J, Li XJ, Wu XT,. HIF-1α expression and relationship involving tumor cell proliferation and angiogenesis in human breast carcinoma. J Sichuan Univ (Medical Science Edtition) 2007; 38: 60-3.